AstraZeneca, Junshi Bio collaborate to commercialize toripalimab in China
Expectations Astrazeneca
For this year the company, based in Cambridge revenue will be around 31.09 billion GBp. This is according to the average of the analysts' estimates. This is hugely more than 2020's revenue of 26.62 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2020
Astrazeneca The analysts expect for 2021 a net profit of 6.83 billion GBp. The majority of the analysts expects for this year a profit per share of 507 GBp. So the price/earnings-ratio equals 13.52.
Huge dividend Astrazeneca
Per share the analysts anticipate on a dividend of 284 GBp per share. Thus the dividend yield equals 4.14 percent. The average dividend yield of the pharmaceutical companies is a low 0.38 percent.Astrazeneca 's market capitalization is based on the number of outstanding shares around 8997.33 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last March the stock is 6 percent lower. This year the stock price moved between 5871 and 10120 GBp.
Historical stock prices Astrazeneca period 2007-2021
Click here for dividend Astrazeneca. At 13.37 the stock trades 0.22 percent higher at 6857 GBp.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
